Medical Condition News

RSS

Mediterranean diet supercharges skin treatment, clears up atopic dermatitis in teen

Study reports on a 14-year-old boy with atopic dermatitis who experienced complete symptom resolution after combining monoclonal antibody treatment with a Mediterranean diet. Highlighting the role of diet in managing inflammatory skin conditions, the case study suggests the therapeutic potential of integrating dietary changes with medical treatment for improved outcomes.

10 Sep 2023

Unlocking the genetic code of blood sugar reveals new diabetes risks and lung complications

The study used a genome-wide association study (GWAS) to analyze random glucose levels in nearly half a million non-diabetic subjects, uncovering 150 distinct genetic signals, including 53 new ones, linked to glycemic traits and type 2 diabetes. The research also discovered a causal effect of random glucose and type 2 diabetes on lung function, identifying lung dysfunction as a new diabetes complication.

10 Sep 2023

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Researchers across Europe have delved into the DNA methylation patterns in CD4+ T-cells of psoriasis and psoriatic arthritis (PsA) patients, unveiling potential new biomarkers for these conditions. Their study suggests that these unique profiles could serve as both diagnostic and prognostic tools, although further validation is needed for real-world clinical application.

10 Sep 2023

Study could pave the way to new treatments for people with compromised immune systems

New research led by Queen’s University Belfast has made a breakthrough in the field of microbiology, which could lead to the development of new treatments for people with compromised immune systems, such as those with cystic fibrosis.

9 Sep 2023

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Findings from a new medical trial, recently published in a prestigious scientific journal, may significantly improve life outcomes for patients with high-risk myeloma.

9 Sep 2023

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

Tiziana Life Sciences Ltd. (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced acceptance of a publication, “Nasal Administration of anti-CD3 monoclonal antibody (mAb) ameliorates disease in a mouse model of Alzheimer’s disease”, in the preeminent journal, Proceedings of the National Academy of Sciences (PNAS), that supports foralumab’s mechanism as a potential treatment for Alzheimer’s disease (AD), a difficult-to-treat neuroinflammatory disease.

9 Sep 2023

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.

9 Sep 2023

Evaluating the efficacy of third dose booster vaccine against SARS-CoV-2 in patients with cancer

A new editorial paper was published in Oncoscience (Volume 10) on September 1, 2023, entitled, "Exiting the pandemic together: achieving global immunity and equity."

8 Sep 2023

Irisin-based therapies may help combat Alzheimer’s disease

Researchers who previously developed the first 3D human cell culture models of Alzheimer's disease (AD) that displays two major hallmarks of the condition - the generation of amyloid beta deposits followed by tau tangles - have now used their model to investigate whether the exercise-induced muscle hormone irisin affects amyloid beta pathology.

8 Sep 2023

BBRF hosts a free webinar on a precision-health approach to bipolar disorder

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, "A Precision-Health Approach to Bipolar Disorder" on Tuesday, September 12, 2023, at 2:00 pm EST.

8 Sep 2023

Research review focuses on the use of psilocybin for treatment of depression

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions.

8 Sep 2023

New way to administer CAR-T-cell therapy could lead to fewer side effects

When Richard O'Neil, Ph.D., joined MUSC Hollings Cancer Center two years ago, he knew that he wanted to continue finding ways to make CAR-T-cell therapy easier on patients.

8 Sep 2023

Capture and release of tumor cells using a bioelectronic device

In the book entitled Microfluidic Systems for Cancer Diagnosis, the UPV/EHU’s Microfluidics Cluster group describes the process for building a bioelectronic device consisting of gold electrodes coated with a smart polymer capable of capturing and releasing cells in a non-invasive, controllable way while monitoring the processes using conventional electrical measurements.

8 Sep 2023

FAU researchers discover novel method to identify therapeutic agents to treat addiction

According to the Substance Abuse and Mental Health Services Administration, approximately 40 million people in the United States had a substance use disorder in 2020.

8 Sep 2023

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

The National Comprehensive Cancer Network today announced the publication of a new supportive care patient guideline focused on preventing and treating cancer-associated blood clots, also known as venous thromboembolism (VTE).

8 Sep 2023

Largest-ever study looks into the genetics of random "round-the-clock" blood glucose levels

Groundbreaking research published today in Nature Genetics describes the largest-ever study into the genetics of random "round-the-clock" blood glucose levels.

8 Sep 2023

First-degree relatives of patients with MASLD have higher risk of developing liver-related diseases

Close relatives of people with metabolic-associated fatty liver disease have a higher risk of developing liver cancer and dying from liver-related diseases, according to a national study from Karolinska Institutet in Sweden published in The Journal of Hepatology.

8 Sep 2023

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

8 Sep 2023

Eye-tracking technology can help improve quality of life assessment for older people with dementia

More than 50% of Australians living in residential aged care facilities have a dementia diagnosis, with aged care services around the world preparing for the number of older people aged 65 years and above to double in the next 30 years.

8 Sep 2023

Breakthrough genome-wide study uncovers new loci impacting apolipoprotein E levels and Alzheimer's risk

New genetic factors that affect the plasma apolipoprotein E levels.

8 Sep 2023

Medical Condition News

Mediterranean diet supercharges skin treatment, clears up atopic dermatitis in teen

Unlocking the genetic code of blood sugar reveals new diabetes risks and lung complications

Is DNA methylation the missing link in diagnosing and treating psoriasis and psoriatic arthritis?

Study could pave the way to new treatments for people with compromised immune systems

Breakthrough trial may improve diagnosis and life outcomes for patients with high-risk myeloma

Study evaluating intranasal anti-CD3 for treatment of Alzheimer’s disease published in the PNAS journal

University of Birmingham and Acticor Biotech announce MHRA approval of LIBERATE clinical study

Evaluating the efficacy of third dose booster vaccine against SARS-CoV-2 in patients with cancer

Irisin-based therapies may help combat Alzheimer’s disease

BBRF hosts a free webinar on a precision-health approach to bipolar disorder

Research review focuses on the use of psilocybin for treatment of depression

New way to administer CAR-T-cell therapy could lead to fewer side effects

Capture and release of tumor cells using a bioelectronic device

FAU researchers discover novel method to identify therapeutic agents to treat addiction

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

Largest-ever study looks into the genetics of random "round-the-clock" blood glucose levels

First-degree relatives of patients with MASLD have higher risk of developing liver-related diseases

Ohio State University Wexner Medical Center administers first targeted gene therapy for ALS

Eye-tracking technology can help improve quality of life assessment for older people with dementia

Breakthrough genome-wide study uncovers new loci impacting apolipoprotein E levels and Alzheimer's risk

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News